Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Bulletin Du Cancer
|
August 21, 2025
[TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)]
Stanislas Quesada, Camille Tlemsani, Christophe Massard, et al.
Expert Opinion on Investigational Drugs
|
September 25, 2023
<i>NF1</i> alterations in cancers: therapeutic implications in precision medicine
Jean-Stéphane Giraud, Ivan Bièche, Éric Pasmant, et al.
NPJ Precision Oncology
|
February 10, 2024
NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients
Jean-Stéphane Giraud, Anne Jouinot, Eric Pasmant, et al.
Targeted Oncology
|
November 18, 2011
Posterior reversible encephalopathy syndrome induced by anti-VEGF agents
Camille Tlemsani, Olivier Mir, Pascaline Boudou-Rouquette, et al.
BMC Palliative Care
|
March 14, 2020
First referral to an integrated onco-palliative care program: a retrospective analysis of its timing
Claire Barth, Isabelle Colombet, Vincent Montheil, et al.
Clinical Nutrition ESPEN
|
October 2, 2022
Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients
Camille Tlemsani, Jean-Philippe Durand, Bruno Raynard, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review
Pascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 21, 2019
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial
Olivier Huillard, Anne Jouinot, Camille Tlemsani, et al.
Annals of Nutrition & Metabolism
|
December 23, 2019
Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer
Guillaume Ulmann, Anne Jouinot, Camille Tlemsani, et al.
European Journal of Radiology
|
August 9, 2024
Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patients
Giorgio Maria Masci, Guillaume Chassagnon, Marco Alifano, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Bulletin Du Cancer
|
August 21, 2025
[TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)]
Stanislas Quesada, Camille Tlemsani, Christophe Massard, et al.
Expert Opinion on Investigational Drugs
|
September 25, 2023
<i>NF1</i> alterations in cancers: therapeutic implications in precision medicine
Jean-Stéphane Giraud, Ivan Bièche, Éric Pasmant, et al.
NPJ Precision Oncology
|
February 10, 2024
NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients
Jean-Stéphane Giraud, Anne Jouinot, Eric Pasmant, et al.
Targeted Oncology
|
November 18, 2011
Posterior reversible encephalopathy syndrome induced by anti-VEGF agents
Camille Tlemsani, Olivier Mir, Pascaline Boudou-Rouquette, et al.
BMC Palliative Care
|
March 14, 2020
First referral to an integrated onco-palliative care program: a retrospective analysis of its timing
Claire Barth, Isabelle Colombet, Vincent Montheil, et al.
Clinical Nutrition ESPEN
|
October 2, 2022
Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients
Camille Tlemsani, Jean-Philippe Durand, Bruno Raynard, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review
Pascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 21, 2019
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial
Olivier Huillard, Anne Jouinot, Camille Tlemsani, et al.
Annals of Nutrition & Metabolism
|
December 23, 2019
Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer
Guillaume Ulmann, Anne Jouinot, Camille Tlemsani, et al.
European Journal of Radiology
|
August 9, 2024
Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patients
Giorgio Maria Masci, Guillaume Chassagnon, Marco Alifano, et al.
Page
of 6